Methylphenidate Transdermal System in Preschool Children with Attention-Deficit/Hyperactivity Disorder

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 4th Text Revision (DSM-IV-TR) Washington, DC: American Psychiatric Association, 2000.

Barkley RA , Edwards G . Diagnostic interview, behavior rating scales, and the medical examination. Russell A. , Barkley . Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis, Treatment, Second. New York: The Guilford Press, 1998; 263–293.

Beck M , Cataldo M , Slifer K , Pulbrook V , Ghuman J . Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills. Clin Pediatr (Phila), 44:515–526. 2005.

Edwards J . Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug? December 7, 2009. www.bnet.com/blog/drug-business/shire-8217s-daytrana-patch-recall-is-8th-so-far-time-to-pull-the-plug/3673. 2011 March 26.

Findling R , Bukstein O , Melmed R , Lopez F , Sallee F , Arnold L , Pratt R . A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry, 69:149–159. 2008.

Findling R , Wigal S , Bukstein O , Boellner S , Abikoff H , Turnbow J , Civil R . Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Clin Ther, 31:1844–1855. 2009.

Frolich M , Giannotti A , Modell J . Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg, 93:647–648. 2001.

Ghuman J , Aman M , Lecavalier L , Riddle M , Gelenberg A , Wright R , Rice S , Ghuman H , Fort C . Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. J Child Adolesc Psychopharmacol, 19:329–339. 2009.

Ghuman JK , Arnold LE , Anthony BJ . Psychopharmacological and other treatments in preschool children with ADHD: Current evidence and practice. J Child Adolesc Psychopharmacol, 18:413–447. 2008.

Ghuman JK , Cataldo MD , Beck MH , Slifer KJ . Behavioral training for pill-swallowing difficulties in young children with autistic disorder. J Child Adolesc Psychopharmacol, 14:601–611. 2004.

Ghuman JK , Ginsburg GS , Subramaniam G , Ghuman HS , Kau AS , Riddle MA . Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: Clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry, 40:516–524. 2001.

Greenhill L , Kollins S , Abikoff H , McCracken J , Riddle M , Swanson J , McGough J , Wigal S , Wigal T , Vitiello B , Skrobala A , Posner K , Ghuman J , Cunningham C , Davies M , Chuang S , Cooper T . Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry, 45:1284–1293. 2006.

Guy W . ECDEU Assessment Manual for Psychopharmacology (Revised) Washington, DC: Department of Health Education and Welfare, 1976.

Hull W . Heat-enhanced drug delivery: A survey paper. J Appl Res Clin Exp Ther, 2:69–76. 2002.

Lord C , Rutter M , DiLavore P , Risi S . Autism Diagnostic Observation Schedule: ADOS: Manual. Los Angeles, CA: Western Psychological Services, 2002.

McDermott: FDA warns consumers not to use Triaminic vapor patch. FDA News, 6–82. 2006.

Noven/Shire: Pharmacokinetics/pharmacodynamics summary NDA 21-514 24 October 2005; 1–43. www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4195B1_01_02-Noven-Appendix-1.pdf. 2011 March 26.

Pappinen S , Urtti A . Microemulsions in topical drug delivery. Smith EW , Maibach HA . Percutaneous Penetration Enhancers, Second. Boca Raton, FL: Taylor & Francis Group, 2005; 109–116.

Patrick K , Straughn A , Perkins J , Gonzalez M . Evolution of stimulants to treat ADHD: Transdermal methylphenidate. Hum Psychopharmacol, 24:1–17. 2009.

Rutter M , LeCouteur A , Lord C . Autism Diagnostic Interview-Revised (ADI-R) Los Angeles, CA: Western Psychological Services, 2003.

Shaffer D , Gould M , Brasic J , Ambrosini P , Fisher P , Bird H , Aluwalia S . A children's global assessment scale (C-GAS) Arch Gen Psychiatry, 40:1228–1231. 1983.

Shire Pharmaceuticals Ireland Limited: Daytrana prescribing information. 2006.

Swanson JM . School-based Assessments and Interventions for ADD Students. Irvine, CA: KC Publishing, 1992.

Wagner M , Markowitz J , Patrick K . Methylphenidate ER tablet lodging in esophagus. J Am Acad Child Adolesc Psychiatry, 40:1244–1245. 2001.

Wigal T , Greenhill L , Chuang S , McGough J , Vitiello B , Skrobala A , Swanson J , Wigal S , Abikoff H , Kollins S , McCracken J , Riddle M , Posner K , Ghuman J , Davies M , Thorp B , Stehli A . Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry, 45:1294–1303. 2006.

Wilens T , Boellner S , Lopez F , Turnbow J , Wigal S , Childress A , Abikoff H , Manos M . Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 47:700–708. 2008.